Results 141 to 150 of about 12,080 (321)
Sugammadex in pediatric patients
Jae Moon Choi, Hong Seuk Yang
openaire +3 more sources
Evaluation of the effects of intra-arterial sugammadex and dexmedetomidine: an experimental study
Background: Intra-arterial injection of medications may cause acute and severe ischemia and result in morbidity and mortality. There is no information in the literature evaluating the arterial endothelial effects of sugammadex and dexmedetomidine.
Volkan Hancı+9 more
doaj +1 more source
Anaphylaxis to Sugammadex [PDF]
L. Savic+2 more
openaire +3 more sources
Sugammadex Versus Neostigmine In Reducing Postoperative Adverse Effects In The Pediatric Population [PDF]
Neostigmine and sugammadex are two medications used to reverse the neuromuscular blockade caused by nondepolarizing aminosteroidal neuromuscular blocking agents.
Vieto, Robert, Jr.
core +1 more source
Sugammadex and laryngospasm [PDF]
S. Greenaway, S. Shah, M. Dancey
openaire +3 more sources
Sugammadex is a novel agent for the reversal of neuromuscular blockade. The speed and efficacy of reversal with sugammadex are significantly faster than acetylcholinesterase inhibitors, such as neostigmine.
Karen Miller+2 more
doaj +1 more source
Reversal of rocuronium‐induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy [PDF]
Hans de Boer+3 more
openalex +1 more source
Dosage of sugammadex according to the calculated lean body mass in obese female patients: time to reverse moderate neuromuscular blockade induced by rocuronium [PDF]
Background: Sugammadex is a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular blockade. The recommended dose is 2 mg/kg.
Bougouma, Cheik Tidiane Hafid Wind-Pouiré+1 more
core +1 more source
Mitigation of rocuronium‐induced anaphylaxis by sugammadex: the great unknown [PDF]
Philip M. Jones, Timothy P. Turkstra
openalex +1 more source
CRNAs and Sugammadex Use: A Qualitative Analysis [PDF]
Background: The availability of Sugammadex has increased options for Certified Registered Nurse Anesthetists’ (CRNAs) and their choice of neuromuscular reversal agents, however administration is impacted by a variety of provider and institutional factors.
Izquierdo, Natalia, BSN, RN+1 more
core +1 more source